Submissions

Focus and Scope

• Public health, epidemiology, and health promotion.
• Maternal and child health, nutrition, and reproductive health.
• Mental health, neurological health, and geriatric health.
• Clinical medicine, nursing, midwifery, and biomedical sciences.
• Pharmacy, halal health products, and evidence-based treatment.
• Islamic medical ethics and bioethics.
• Health practices in Muslim communities, including pesantren health and Hajj-related health.

Studies on psychological well-being without a primary clinical or health-science outcome should be directed to MUTMAINNAH.

Types of Manuscripts Accepted

General Manuscript Requirements

Abbreviations, Units, and Drug Names

• Use abbreviations sparingly and only when standard. Spell each abbreviation out at first mention in both the abstract and main text. Do not use abbreviations in the title.
• Use International System (SI) units. Report temperature in degrees Celsius (°C) and blood pressure in mmHg.
• Use generic drug names.
• Do not begin a sentence with a numeral.

Title, Authors, Abstract, and Keywords

• The title is no more than 16 words and identifies the health problem, population, and study design where appropriate.
• Author names are written in full without academic degrees. Affiliations, corresponding-author email, and ORCID iD are included in the manuscript according to the template and completed in OJS metadata.
• Authorship follows ICMJE criteria. Each author should make a substantive contribution to the work, participate in drafting or critical revision, approve the final version, and accept accountability for the content.
• The structured abstract is no more than 250 words and uses four headings: Background, Methods, Results, and Conclusion. It contains no citations and uses abbreviations only where necessary.
• Provide 3–6 keywords selected from MeSH where possible.

Illustrative structured abstract (format example, not real data):

Background: Anemia among adolescent girls can affect learning concentration and reproductive health. This study analysed factors associated with anemia among female pesantren students.

Methods: A cross-sectional study involved 210 female students aged 12–18 years from three pesantren. Hemoglobin was measured using a hemoglobinometer, iron intake was assessed by two 24-hour food recalls, and data were analysed using logistic regression.

Results: Anemia prevalence was 34.3%. Low iron intake (OR = 2.8; 95% CI 1.5–5.2) and eating twice daily (OR = 2.1; 95% CI 1.1–4.0) were associated with anemia.

Conclusion: Iron-supplementation programs and improvement of pesantren meal planning should be prioritised.

Keywords: anemia; adolescent; iron intake; pesantren

Article Structure

1. Introduction: magnitude of the health problem, studies from the last 10 years, research gap, and objective.
2. Methods: design, setting and period, population and sample, variables, instruments, analysis, and ethics approval.
3. Results: participant characteristics and univariate, bivariate, and multivariable analyses.
4. Discussion: meaning of findings, comparison, mechanisms, Islamic perspective where relevant, and limitations.
5. Conclusion: answer to the objective and program recommendation in one paragraph.

After the Conclusion, include Acknowledgments and Funding, Conflict of Interest, Author Contributions, Generative AI Statement, and References. Case reports use Introduction, Case Presentation, Discussion, and Conclusion, together with written patient or guardian consent for publication.

Methods and Reporting Requirements

• Report study design, setting and period, population, inclusion and exclusion criteria, sample-size calculation, and sampling technique.
• Define study variables operationally and report instruments or devices, including manufacturer and country where relevant.
• Describe data-collection procedures and intervention protocols where applicable.
• Identify statistical analyses and the software and version used.
• Report the research-ethics approval number and informed-consent procedures.

وَكُلُوا وَاشْرَبُوا وَلَا تُسْرِفُوا ۚ إِنَّهُ لَا يُحِبُّ الْمُسْرِفِينَ

(Qur'an 7:31)

Reporting Guidelines

Authors must follow the appropriate reporting guideline for the study design and upload the completed checklist as a supplementary file. Use EQUATOR Network guidance.

Health Research Ethics

• Research involving humans, medical records, biological samples, or animals must obtain approval from an accredited health-research ethics committee where required. Report the approval number in Methods and upload the approval letter.
• Human research should state compliance with the Declaration of Helsinki and relevant amendments.
• All participants provide informed consent. Participants under 18 require parent or guardian consent and, where appropriate, child assent.
• Do not disclose names, medical-record numbers, or identifiable patient photographs without appropriate authorization.
• Randomized clinical trials are encouraged to register in a recognized trial registry and report the registration number.
• For studies not involving humans or patient data, such as literature reviews, state this clearly in Methods.

Statistical Reporting, Tables, and Figures

• Do not report p values alone; include effect sizes and confidence intervals where appropriate.
• Identify the statistical test used for each analysis and report the analysis software and version.
• Report percentages together with absolute numbers, for example 72 (34.3%).
• Normally distributed data may be reported as mean ± standard deviation; non-normal data as median (interquartile range).
• Use a comma as decimal separator in Indonesian manuscripts and a period in English manuscripts.

Tables and Figures

• The combined total of tables and figures should not exceed 6.
• Tables are numbered in order of appearance, titled above the table, and use no vertical rules.
• Table footnotes use symbols in sequence: *, †, ‡, §, ¶.
• Figures should be at least 300 dpi in JPEG or TIFF format with captions below.
• Microscopic images should include a scale marker and staining method.
• Material reproduced from other sources requires permission unless openly licensed.

Citation and References (Vancouver)

AL-WIQAYAH uses Vancouver style following National Library of Medicine conventions. Citations are Arabic superscript numbers in order of first appearance, and the reference list is numerical rather than alphabetical.

• Use the same reference number for repeated citations to the same source.
• Abbreviate journal titles according to the NLM Catalog.
• For more than six authors, list the first six followed by et al.
• Use 20–40 references; at least 80% should be journal articles published within the last 10 years, except where older classic methods are necessary.
• Qur'anic verses and hadith may be cited in text where relevant; classical books cited as sources appear in the reference list.
• Use Mendeley, Zotero, or EndNote with Vancouver style.

Publication Ethics, Data, and Generative AI

• AL-WIQAYAH follows COPE guidance and ICMJE recommendations.
• Plagiarism, duplicate publication, fabricated or falsified data, image manipulation, breaches of patient confidentiality, and authorship or citation manipulation may lead to rejection or retraction.
• Authors are encouraged to share anonymized research data in an appropriate repository or explain why data cannot be shared.
• Generative AI may assist with language or translation but cannot be listed as an author.
• AI must not be used to fabricate data, laboratory findings, clinical images, analyses, or references.
• Confidential patient data must never be entered into external AI services.
• Material AI use must be disclosed, including the tool, version where relevant, and the part assisted.

Submission Checklist

• Author names, affiliations, corresponding-author email, and ORCID identifiers are included in the manuscript and OJS metadata.
• The title contains no more than 16 words and no abbreviations.
• Structured Indonesian and English abstracts are each no more than 250 words.
• There are 3–6 MeSH-based keywords.
• The Methods section reports ethics approval and informed consent where applicable.
• The appropriate reporting checklist (CONSORT, STROBE, PRISMA, CARE, COREQ/SRQR, or STARD) is complete.
• Statistical reporting includes effect sizes and confidence intervals where appropriate.
• The combined total of tables and figures does not exceed 6.
• Vancouver superscript citation style is used and the manuscript contains 20–40 references.
• SI units and generic drug names are used.
• Similarity is no more than 20%.
• Funding, conflicts of interest, author contributions, and AI-use statements are complete.

Submission, Review, Fees, and Copyright

Submission

Manuscripts are submitted through OJS at journal.cendekiajurnalhub.com using the AL-WIQAYAH template. Author information is included in the manuscript and completed in OJS metadata. Ethics approval letters, consent documents where relevant, and reporting checklists are uploaded as supplementary files.

Review

1. The Editor-in-Chief screens scope, format, research ethics, and similarity.
2. Eligible manuscripts are sent to at least two reviewers for peer review; a statistical reviewer may be involved where needed.
3. Decisions are: accepted, minor revision, major revision, or rejected. Revised manuscripts are normally returned within two weeks.

Fees

There is no submission or review fee. The Article Processing Charge (APC) of IDR 100,000 is paid after acceptance.

Copyright and License

Authors retain copyright. Articles are published open access under the Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0) license.

After Acceptance

• A Letter of Acceptance is issued after the final revision is approved and the APC is paid.
• The editorial team may edit language, medical terminology, and formatting without changing the scholarly substance.
• Authors review the galley proof within three working days, paying particular attention to numbers, doses, and units.
• Accepted articles are scheduled for the nearest available January, May, July, or November issue.
• Withdrawal may be requested through OJS before peer review begins. Appeals against editorial decisions should be submitted in writing within 14 days.

Download Article Template (.docx) Submit an Article